Tcelltech Inc.
Clinical trials sponsored by Tcelltech Inc., explained in plain language.
-
Engineered immune cells take on deadliest brain tumors
Disease control Recruiting nowThis early-phase study tests a new treatment called TX103 CAR-T cells for people with a severe and fast-growing brain cancer (grade 4 glioma) that has come back or worsened. The therapy uses a patient's own immune cells, modified in a lab to better recognize and attack cancer cel…
Phase: PHASE1 • Sponsor: Tcelltech Inc. • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Engineered immune cells take on Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called TX103 CAR-T cells in 85 adults with advanced solid tumors that have not responded to standard therapy. The therapy uses a patient's own immune cells, modified to target a protein (B7-H3) on cancer cells. The main goals are to ch…
Phase: PHASE1 • Sponsor: Tcelltech Inc. • Aim: Disease control
Last updated Apr 28, 2026 13:10 UTC